These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 25958657)

  • 21. Therapeutic Use Exemptions.
    Gerrard D; Pipe A
    Med Sport Sci; 2017; 62():55-67. PubMed ID: 28571022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The list of prohibited substances and methods in sport: structure and review process by the world anti-doping agency.
    Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):608-12. PubMed ID: 22080899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to justify a ban on doping?
    Breitsameter C
    J Med Ethics; 2017 May; 43(5):287-292. PubMed ID: 27491325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doping in competition or doping in sport?
    Lippi G; Franchini M; Guidi GC
    Br Med Bull; 2008; 86():95-107. PubMed ID: 18385161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015.
    Dvorak J; Baume N; Botré F; Broséus J; Budgett R; Frey WO; Geyer H; Harcourt PR; Ho D; Howman D; Isola V; Lundby C; Marclay F; Peytavin A; Pipe A; Pitsiladis YP; Reichel C; Robinson N; Rodchenkov G; Saugy M; Sayegh S; Segura J; Thevis M; Vernec A; Viret M; Vouillamoz M; Zorzoli M
    Br J Sports Med; 2014 May; 48(10):801-6. PubMed ID: 24764550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
    Smith R; Barnsley L; Kannangara S; Mace A
    Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2011 Jan; 3(1):1-14. PubMed ID: 21254451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The athlete biological passport: an effective tool in the fight against doping.
    Robinson N; Saugy M; Vernec A; Pierre-Edouard S
    Clin Chem; 2011 Jun; 57(6):830-2. PubMed ID: 21482746
    [No Abstract]   [Full Text] [Related]  

  • 32. [Every physician must be familiar with the doping list. Doping classified substances should be avoided for athletes--sometimes dispensation is necessary].
    Eriksson BO
    Lakartidningen; 2012 Jul 18-Aug 8; 109(29-31):1345-6. PubMed ID: 22913115
    [No Abstract]   [Full Text] [Related]  

  • 33. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and threats to implementing the fight against doping in sport.
    Dvorak J; Saugy M; Pitsiladis YP
    Br J Sports Med; 2014 May; 48(10):807-9. PubMed ID: 24764551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sports physicians, ethics and antidoping governance: between assistance and negligence.
    Dikic N; McNamee M; Günter H; Markovic SS; Vajgic B
    Br J Sports Med; 2013 Jul; 47(11):701-4. PubMed ID: 23322892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [World Football Championship 2006--anti-doping regulations].
    Wolfarth B; Graf-Baumann T; Halle M
    MMW Fortschr Med; 2006 Jun; 148(23):41-3. PubMed ID: 16826737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Half a century of challenges.
    Ljungqvist A
    Bioanalysis; 2012 Jul; 4(13):1531-3. PubMed ID: 22831467
    [No Abstract]   [Full Text] [Related]  

  • 39. Current implementation and future of the Athlete Biological Passport.
    Sottas PE; Vernec A
    Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A conceptual framework for achieving performance enhancing drug compliance in sport.
    Donovan RJ; Egger G; Kapernick V; Mendoza J
    Sports Med; 2002; 32(4):269-84. PubMed ID: 11929355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.